Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.

Breast cancer research : BCR - 26 Feb 2015

Wang Qing-Shan, Kong Peng-Zhou, Li Xiao-Qing, Yang Fan, Feng Yu-Mei

Abstract excerpt

INTRODUCTION: Our previous clinical study demonstrated that the under-expression of FOXF2 is associated with early-onset metastasis and poor prognosis of patients with triple-negative breast cancer. In this study, we further characterized the role of FOXF2 in metastasis of basal-like breast cancer (BLBC) and underlying molecular mechanisms. METHODS: RT-qPCR, immunoblot, immunofluorescence and immunohistochemistry...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Basal Cell
Share to Cell Movement

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epithelial Cells

Share to Epithelial-Mesenchymal Transition

Share to Forkhead Transcription Factors

Share to Heterografts

Share to Neoplasm Metastasis

Share to Twist-Related Protein 1

Source

Open in PubMed Open full text

Identifiers

PMID: 25848863
DOI: 10.1186/s13058-015-0531-1
PMCID: PMC4361145

Genes

FOXF2
TWIST1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.PMID 25848863Read ↗

FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.Semantic proximity Read ↗

Mesenchyme Forkhead 1 ( <i>FOXC2</i> ) plays a key role in metastasis and is associated with aggressive basal-like breast cancersSemantic proximity Read ↗

WNT5B governs the phenotype of basal-like breast cancer by activating WNT signalingSemantic proximity Read ↗

Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancerSemantic proximity Read ↗

The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expressionSemantic proximity Read ↗

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progressionSemantic proximity Read ↗

POLD2 is activated by E2F1 to promote triple-negative breast cancer proliferationSemantic proximity Read ↗

Trop2 is a potential biomarker for the promotion of EMT in human breast cancerSemantic proximity Read ↗

WNT signaling pathway regulator-FRAT2 affects oncogenesis and prognosis of basal-like breast cancerSemantic proximity Read ↗

FBLN2 is associated with basal cell markers Krt14 and ITGB1 in mouse mammary epithelial cells and has a preferential expression in molecular subtypes of human breast cancerSemantic proximity Read ↗

FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cellsSemantic proximity Read ↗

The Kindlin-2 regulation of epithelial-to-mesenchymal transition in breast cancer metastasis is mediated through miR-200bSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.